Transfusion of human platelets treated with Mirasol pathogen reduction technology does not induce acute lung injury in mice

PLoS ONE

Volumn 10, Issue 7, 2015, Pages

  Caudrillier, Axelle ^a   Mallavia, Beñat ^a   Rouse, Lindsay ^b   Marschner, Susanne ^b   Looney, Mark R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Terumo BCT Inc ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPOLYSACCHARIDE; MONOCLONAL ANTIBODY; PADGEM PROTEIN; THROMBIN RECEPTOR ACTIVATING PEPTIDE; PEPTIDE FRAGMENT; PHOTOSENSITIZING AGENT; RIBOFLAVIN; THROMBIN RECEPTOR-ACTIVATING PEPTIDE (P508-530);

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; LUNG CIRCULATION; LUNG EXTRAVASCULAR FLUID; MOUSE; NONHUMAN; PATHOGEN REDUCTION SYSTEM; PROTEIN EXPRESSION; THROMBOCYTE; THROMBOCYTE PRESERVATION; THROMBOCYTE TRANSFUSION; TRANSFUSION RELATED ACUTE LUNG INJURY; ACUTE LUNG INJURY; ANIMAL; BLOOD SAFETY; BLOOD STORAGE; CAPILLARY PERMEABILITY; CHEMISTRY; CYTOLOGY; FLOW CYTOMETRY; INTRAVITAL MICROSCOPY; METABOLISM; NONOBESE DIABETIC MOUSE; PATHOLOGY; SCID MOUSE;

ACUTE LUNG INJURY; ANIMALS; BLOOD PLATELETS; BLOOD PRESERVATION; BLOOD SAFETY; CAPILLARY PERMEABILITY; FLOW CYTOMETRY; HUMANS; INTRAVITAL MICROSCOPY; MICE; MICE, INBRED NOD; MICE, SCID; P-SELECTIN; PEPTIDE FRAGMENTS; PHOTOSENSITIZING AGENTS; PLATELET TRANSFUSION; RIBOFLAVIN;

EID: 84941266257     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0133022     Document Type: Article

References (17)

1. Dwyre DM, Fernando LP, Holland PV. Hepatitis B, hepatitis C and HIV transfusion-transmitted infections in the 21st century. Vox Sanguinis. 2011; 100(1):92-8. doi: 10.1111/j.1423-0410.2010.01426.x PMID: 21175659
2. Spinella PC. Warm fresh whole blood transfusion for severe hemorrhage: U.S. military and potential civilian applications. Crit Care Med. 2008; 36(7 Suppl):S340-5. doi: 10.1097/CCM.0b013e31817e2ef9 PMID: 18594261
3. Schlenke P. Pathogen inactivation technologies for cellular blood components: an update. Transfus Med Hemother. 2014; 41(4):309-25. doi: 10.1159/000365646 PMID: 25254027
4. Snyder E, McCullough J, Slichter SJ, Strauss RG, Lopez-Plaza I, Lin JS, et al. Clinical safety of platelets photochemically treated with amotosalen HCl and ultraviolet A light for pathogen inactivation: the SPRINT trial. Transfusion. 2005; 45(12):1864-75. PMID: 16371039
5. Caudrillier A, Kessenbrock K, Gilliss BM, Nguyen JX, Marques MB, Monestier M, et al. Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury. J Clin Invest. 2012; 122(7):2661-71. doi: 10.1172/JCI61303 PMID: 22684106
6. Looney MR, Nguyen JX, Hu Y, Van Ziffle JA, Lowell CA, Matthay MA. Platelet depletion and aspirin treatment protect mice in a two-event model of transfusion-related acute lung injury. J Clin Invest. 2009; 119(11):3450-61. doi: 10.1172/JCI38432 PMID: 19809160
7. Looney MR, Su X, Van Ziffle JA, Lowell CA, Matthay MA. Neutrophils and their Fc gamma receptors are essential in a mouse model of transfusion-related acute lung injury. J Clin Invest. 2006; 116 (6):1615-23. PMID: 16710475
8. Ortiz-Munoz G, Mallavia B, Bins A, Headley M, Krummel MF, Looney MR. Aspirin-triggered 15-epilipoxin A4 regulates neutrophil-platelet aggregation and attenuates acute lung injury in mice. Blood. 2014; 124(17):2635-34. doi: 10.1182/blood-2014-03-562876 PMID: 25143486
9. Goodrich RP, Edrich RA, Li J, Seghatchian J. The Mirasol PRT system for pathogen reduction of platelets and plasma: an overview of current status and future trends. Transfus Apher Sci. 2006; 35(1):5-17. PMID: 16935562
10. Looney MR, Thornton EE, Sen D, Lamm WJ, Glenny RW, Krummel MF. Stabilized imaging of immune surveillance in the mouse lung. Nat Methods. 2011; 8(1):91-6. doi: 10.1038/nmeth.1543 PMID: 21151136
11. Cookson P, Thomas S, Marschner S, Goodrich R, Cardigan R. In vitro quality of single-donor platelets treated with riboflavin and ultraviolet light and stored in platelet storage medium for up to 8 days. Transfusion. 2012; 52(5):983-94. doi: 10.1111/j.1537-2995.2011.03388.x PMID: 22014032
12. Zarbock A, Singbartl K, Ley K. Complete reversal of acid-induced acute lung injury by blocking of platelet- neutrophil aggregation. J Clin Invest. 2006; 116(12):3211-9. PMID: 17143330
13. Shultz LD, Schweitzer PA, Christianson SW, Gott B, Schweitzer IB, Tennent B, et al. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J Immunol. 1995; 154(1):180-91. PMID: 7995938
14. Fung YL, Kim M, Tabuchi A, Aslam R, Speck ER, Chow L, et al. Recipient T lymphocytes modulate the severity of antibody-mediated transfusion-related acute lung injury. Blood. 2010; 116(16):3073-9. doi: 10.1182/blood-2010-05-284570 PMID: 20616220
15. Chi X, Zhi L, Vostal JG. Human platelets pathogen reduced with riboflavin and ultraviolet light do not cause acute lung injury in a two-event SCID mouse model. Transfusion. 2014; 54(1):74-85. doi: 10. 1111/trf.12242 PMID: 23656563
16. Chi X, Zhi L, Gelderman MP, Vostal JG. Host platelets and, in part, neutrophils mediate lung accumulation of transfused UVB-irradiated human platelets in a mouse model of acute lung injury. PLoS One. 2012; 7(9):e44829. doi: 10.1371/journal.pone.0044829 PMID: 23028636
17. Gelderman MP, Chi X, Zhi L, Vostal JG. Ultraviolet B light-exposed human platelets mediate acute lung injury in a two-event mouse model of transfusion. Transfusion. 2011; 51(11):2343-57. doi: 10.1111/j. 1537-2995.2011.03135.x PMID: 21492179